Chlamydia in Emerald Tree Boas

Chlamydial bacteria are obligate intracellular pathogens, meaning they can only replicate inside living host cells. Several species within the family Chlamydiaceae have been documented in captive reptiles, and Emerald Tree Boas specifically have been the subject of published research. Chlamydophila pneumoniae was identified in a collection of Corallus caninus (Jacobson et al., 2004), and a distinct novel species, Candidatus Chlamydia corallus, was later described from the choana of a captive Amazon Basin Emerald Tree Boa (Corallus batesii), demonstrating that chlamydial diversity in this genus extends beyond the strains typically associated with other reptile species. An earlier study documented a large-scale epizootic of chronic regurgitation associated with chlamydophilosis in wild-caught C. caninus, with cumulative mortality reaching 51% across a collection of 120 animals over a 23-month period (Lock et al., 2003).

These findings make chlamydia a condition any serious ETB keeper should understand, even if clinical disease in captive-bred animals remains less well documented than in wild-caught populations.

This page is for informational purposes only and does not constitute veterinary advice. If you suspect your animal is unwell, contact a reptile-experienced veterinarian promptly.

What Chlamydial Bacteria Are

Chlamydiales are gram-negative bacteria with a distinctive biphasic lifecycle. Outside a host cell, they exist as metabolically inactive elementary bodies capable of surviving in the environment briefly and initiating new infections. Once inside a host cell, they convert to reticulate bodies that replicate actively before reorganizing into new elementary bodies and spreading to adjacent tissue. This intracellular lifecycle makes chlamydiae inherently difficult to eliminate: most common antibiotics that work by disrupting cell wall synthesis have no effect on them, and treatment must rely on agents capable of penetrating host cells to reach the organism.

The taxonomy of chlamydiae in snakes is an active area of research. Beyond C. pneumoniae and the novel Candidatus species already linked to ETBs, two additional species, Chlamydia serpentis and Chlamydia poikilothermis, have been isolated from captive snakes in Swiss collections. Both showed sensitivity to tetracyclines and moxifloxacin in vitro, but intermediate to reduced susceptibility to azithromycin, which has important implications for treatment selection.

Clinical Signs

Chlamydial infection in ETBs does not produce a single recognizable syndrome, and many infected animals show no external signs at all. Where disease does become apparent, the most documented presentation is chronic, repetitive regurgitation occurring a few days after feeding. This was the primary finding in the Florida epizootic described by Lock et al. (2003), where affected C. caninus regurgitated consistently three to four days post-feeding over many months. Hematological findings in that outbreak included anemia, elevated white cell counts with lymphocytosis, monocytosis, and azurophilia, all consistent with a significant systemic inflammatory response.

Histopathology in confirmed cases has revealed histiocytic granulomas in the small intestine, heart, and esophageal tonsils, with chlamydial antigen confirmed by immunohistochemical staining and electron microscopy. In some snake populations studied for other conditions, chlamydial organisms have been detected in granulomatous lesions alongside mycobacteria, underscoring how these findings can overlap with other diseases on necropsy.

Possible signs to monitor in a living animal include:

  • Chronic regurgitation, particularly occurring consistently a few days after feeding

  • Unexplained weight loss despite an established feeding schedule

  • Lethargy or posture changes inconsistent with the animal's normal resting behavior

  • Respiratory changes, particularly in C. batesii, which is more sensitive to any respiratory compromise

  • Decline in overall condition without an identifiable husbandry cause

None of these signs are specific to chlamydia. Chronic regurgitation in particular has a broad differential list, including husbandry errors, regurgitation disease, internal parasites, and other bacterial infections. Definitive diagnosis requires laboratory testing.

Amazon Basin Emerald Tree Boas and Chlamydia

Corallus batesii is larger, strictly nocturnal, and more physiologically sensitive than the Northern ETB. The discovery of Candidatus Chlamydia corallus from a Basin ETB choanal sample indicates that this species has its own distinct chlamydial diversity that is not yet fully characterized. More broadly, the respiratory sensitivity of C. batesii means that any systemic infection carrying even a minor respiratory component warrants earlier and more aggressive veterinary evaluation in this species than might be typical for C. caninus.

Basin keepers already managing the species' higher humidity requirements and stringent ventilation needs should understand that suboptimal environmental conditions can compound the impact of an underlying infection by reducing the animal's already narrower physiological tolerance margins. A Basin ETB in a collection where chlamydia is suspected should be isolated immediately and assessed by a veterinarian familiar with large arboreal constrictors.

Diagnosis

Chlamydia in snakes cannot be reliably diagnosed based on clinical signs alone. Definitive confirmation requires laboratory testing, and several modalities are used depending on what samples are available and what the animal's status is.

PCR testing of choanal or cloacal swabs is the most practical antemortem option and is included on some reptile pathogen panels offered by veterinary diagnostic laboratories. However, PCR has limitations in this context: a positive result confirms the presence of chlamydial DNA but does not by itself indicate the species involved or the clinical significance in that individual. A negative swab does not rule out infection in deeper tissues. Multiple sample types, including swabs from both choanal and cloacal sites, improve sensitivity.

Histopathology of tissue samples, either from biopsy or necropsy, can reveal granulomatous lesions consistent with chlamydial infection. Immunohistochemistry using antibodies against chlamydial lipopolysaccharide antigen can then confirm the organism's presence within those granulomas. Electron microscopy of granuloma samples showing the characteristic developmental stages of chlamydial organisms has been used in research settings.

Serology (antibody detection) has been used in some species but is less well validated for snakes. No single test is definitively conclusive in all cases, and a reptile-experienced veterinarian will typically combine testing results with clinical history, physical exam findings, and husbandry review before reaching a diagnostic conclusion. See the Diagnostic Testing page for an overview of PCR and panel testing options.

Treatment

Chlamydiae are susceptible to tetracyclines and certain fluoroquinolones. Doxycycline is the most commonly referenced antibiotic in the reptile chlamydia literature and is generally considered first-line where treatment is undertaken. Oxytetracycline was used in the Lock et al. (2003) ETB epizootic and was reported to reduce regurgitation rates in affected animals. Marbofloxacin, a fluoroquinolone, has been used successfully in captive snake collections with confirmed C. pneumoniae, with five of seven treated animals converting to PCR-negative status following a treatment course (Ruegg et al., 2015).

In vitro susceptibility testing of the novel snake-specific chlamydial species C. serpentis and C. poikilothermis showed sensitivity to tetracyclines and moxifloxacin but reduced susceptibility to azithromycin, suggesting azithromycin may be a poor choice for snake chlamydial infections even where it might be used in other host species.

Treatment duration for chlamydial infections is typically prolonged. In avian species, treatment courses of 45 days or longer have historically been standard; reptile-specific duration guidelines are less firmly established and will depend on the species involved, the animal's condition, and the veterinarian's assessment.

Supportive care matters significantly alongside antibiotic therapy. An animal dealing with chronic regurgitation will be losing condition rapidly, and maintaining hydration and body weight while treatment proceeds is essential. Animals should be isolated from the rest of the collection during treatment. See the Quarantine and Cleaning pages for protocols relevant to managing an affected animal.

Treatment decisions must be made in consultation with a reptile-experienced veterinarian. Drug selection, dosing, and duration are not one-size-fits-all and must be tailored to the individual animal by a qualified clinician.

Transmission and Collection Management

The Florida epizootic documented by Lock et al. (2003) provides the clearest example of how chlamydia can move through an ETB collection. The introduction of 105 wild-caught animals into a collection of 15 established snakes led to disease spreading to both groups, with the peak monthly prevalence of regurgitation reaching over 40% at one point. This pattern is consistent with direct contact or shared airspace facilitating transmission, though the exact routes in snakes are not fully characterized.

Wild-caught animals represent the highest risk category for introducing chlamydia into a captive collection. Rigorous quarantine of any new acquisition, and especially any wild-caught animal, is the single most effective management step a keeper can take. A standard 90-day minimum quarantine with strict hygiene separation is the baseline; animals from unknown health histories warrant extended observation and ideally PCR screening before introduction to an established collection.

Enclosure cleaning and disinfection protocols matter in any situation where chlamydia is suspected. Chlamydial elementary bodies can survive briefly outside a host, and shared equipment, water sources, or inadequately sanitized surfaces represent potential transmission pathways. Disinfectants effective against chlamydiae include dilute bleach solutions and quaternary ammonium compounds at appropriate concentrations.

Relationship to Other Diseases

Chlamydia is not the only cause of chronic regurgitation in ETBs, and a keeper encountering persistent regurgitation should not assume chlamydia without testing. Other conditions on the differential list include regurgitation disease, cryptosporidiosis, Helicobacter infection, and other gastrointestinal pathogens. Nidovirus and Ophidian Paramyxovirus can produce overlapping respiratory and systemic signs. In necropsy studies, chlamydial organisms have been found alongside mycobacteria in granulomatous lesions, indicating co-infections are possible.